Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors

Abstract

Low oxygen tension (hypoxia) is a common feature of solid tumors and stimulates the expressions of a variety of genes including those related to angiogenesis, apoptosis and endoplasmic reticulum (ER) stress response. Here we show a close correlation between metastatic potential and the resistance to hypoxia- and ER stress-induced apoptosis among the cell lines with differing metastatic potential derived from Lewis lung carcinoma. An apoptosis-specific expression profiling and immunoblot analyses revealed that the expression of antiapoptotic Mcl-1 increased as the resistance to apoptosis increased. Downregulation of the Mcl-1 expression in the high-metastatic cells by Mcl-1 small interfering RNA increased the sensitivity to hypoxia-induced apoptosis and decreased the metastatic ability. The hypoxia-induced apoptosis was not associated with p53 accumulation, although at present it is not possible to conclude that apoptosis-induced apoptosis is p53-independent. There was no correlation between the expression levels of ER stress-response proteins GADD153, GRP78 and ORP150 and the resistance to hypoxia or ER stresses. In vitro, small numbers of the high-metastatic cells overtook the low-metastatic cells after exposure to several rounds of hypoxia and reoxygenation. In solid tumors initially established from equal mixtures, the proportion of the high-metastatic cells to low-metastatic cells was significantly higher in hypoxic areas. Moreover, the high-metastatic cells were overtaking the low-metastatic cells in some of the tumors. Thus, tumor hypoxia and ER stress may provide a physiological selective pressure for the expansion of the high-metastatic cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR et al. (1996). Cancer Res 56: 941–943.

  • Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW . (1997). Int J Radiat Oncol Biol Phys 38: 285–289.

  • Brown JM, Giaccia AJ . (1998). Cancer Res 58: 1408–1416.

  • Bruick RK . (2000). Proc Natl Acad Sci USA 97: 9082–9087.

  • Bufalo DD, Biroccio A, Leonetti C, Zupi G . (1997). FASEB J 11: 947–953.

  • Cairns RA, Kalliomaki T, Hill RP . (2001). Cancer Res 61: 8903–8908.

  • Chaplin DJ, Hill SA . (1995). Br J Cancer 71: 1210–1213.

  • Coquelle A, Toledo F, Stern S, Bieth A, Debatisse M . (1998). Mol Cell 2: 259–265.

  • Dachs GU, Chaplin DJ . (1998). Semin Radiat Oncol 8: 208–216.

  • Durand RE, Sham E . (1998). Int J Radiat Oncol Biol Phys 42: 711–715.

  • Fernandez Y, Espana L, Manas S, Fabra A, Sierra A . (2000). Cell Death Differ 7: 350–359.

  • Friedman AD . (1996). Cancer Res 56: 3250–3256.

  • Glinsky GV . (1997). Crit Rev Oncol Hematol 25: 175–186.

  • Glinsky GV, Glinsky VV . (1996). Cancer Lett 101: 43–51.

  • Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW et al. (1996). Nature 379: 88–91.

  • Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S . (1999). Int J Cancer 80: 617–623.

  • Guo K, Searfoss G, Krolikowski D, Pagnoni M, Franks C, Clark K et al. (2001). Cell Death Differ 8: 367–376.

  • Harris AL . (2002). Nat Rev 2: 38–47.

  • Hill RP . (1990). Cancer Metastasis Rev 9: 137–147.

  • Höckel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P . (1996). Cancer Res 56: 4509–4515.

  • Höckel M, Schlenger K, Höckel S, Vaupel P . (1999). Cancer Res 59: 4525–4528.

  • Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L et al. (1997). Nature 390: 180–184.

  • Kim CY, Tsai MH, Osmanian C, Graeber TG, Lee JE, Giffard RG et al. (1997). Cancer Res 57: 4200–4204.

  • Kinoshita M, Johnson DL, Shatney CH, Lee YL, Mochizuki H . (2001). Int J Cancer 91: 322–326.

  • Koshikawa N, Iyozumi A, Gassmann M, Takenaga K . (2003). Oncogene 22: 6717–6724.

  • Kuwabara K, Matsumoto M, Ikeda J, Hori O, Ogawa S, Maeda Y et al. (1996). J Biol Chem 271: 5025–5032.

  • Lord EM, Harwell L, Koch CJ . (1993). Cancer Res 53: 5721–5726.

  • Lowe SW, Lin AW . (2000). Carcinogenesis 21: 485–495.

  • Maeta Y, Tsujitani S, Matsumoto S, Yamaguchi K, Tatebe S, Kondo A et al. (2004). Gastric Cancer 7: 78–84.

  • McConkey DJ, Greene G, Pettaway CA . (1996). Cancer Res 56: 5594–5599.

  • Munro S, Pelham HR . (1986). Cell 46: 291–300.

  • Piret JP, Minet E, Cosse JP, Ninane N, Debacq C, Raes M et al. (2005). J Biol Chem 280: 9336–9344.

  • Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC et al. (2000). J Biol Chem 275: 1439–1448.

  • Rice GC, Hoy C, Schimke RT . (1986). Proc Natl Acad Sci USA 83: 5978–5982.

  • Russo CA, Weber TK, Volpe CM, Stoler DL, Petrelli NJ, Rodriguez-Bigas M et al. (1995). Cancer Res 55: 1122–1128.

  • Semenza GL . (2000). Crit Rev Biochem Mol Biol 35: 71–103.

  • Semenza GL . (2002). Trends Mol Med 8: S62–S67.

  • Shtivelman E . (1997). Oncogene 14: 2167–2173.

  • Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y et al. (1997). Oncogene 14: 2871–2977.

  • Takasu M, Tada Y, Wang JO, Tagawa M, Takenaga K . (1999). Clin Exp Metastasis 17: 409–416.

  • Teicher BA . (1994). Cancer Metastasis Rev 13: 139–168.

  • Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S et al. (2000). Mol Cell Biol 20: 5454–5468.

  • Wong CW, Lee A, Shientag L, Yu J, Dong Y, Kao G et al. (2001). Cancer Res 61: 333–338.

  • Young SD, Hill RP . (1990). J Natl Cancer Inst 82: 371–380.

Download references

Acknowledgements

We thank the National Cancer Institute (CTEP) for providing EF5. This work was supported in part by Grant-in-Aid from the Ministry of Health, Labour, and Welfare for Third Term Comprehensive Control Research for Cancer and from the Ministry of Education, Culture, Sports, Science and Technology.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Takenaga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koshikawa, N., Maejima, C., Miyazaki, K. et al. Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors. Oncogene 25, 917–928 (2006). https://doi.org/10.1038/sj.onc.1209128

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209128

Keywords

This article is cited by

Search

Quick links